1. The Changing Landscape of Research and Development: Innovation, Drivers of Change, and Evolution of Clinical Trial Productivity;Aitken,2019
2. ICH S7A: Safety Pharmacology Studies for Human Pharmaceuticals;Anonymous,2000
3. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non- antiarrhythmic drugs;Anonymous,2005
4. ICH S7B: The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals;Anonymous,2005
5. ICH E14 Guideline: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs - Questions & Answers (R3);Anonymous,2015